Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists.

Transl Lung Cancer Res · 2021 · PMC8107728 · PMID 34012806

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Overall, with increasing volume or extent of N2 disease, there was an increasing trend towards therapy based on RT.

also in 63,971 other papers

highly significantno p-value reported

This is a highly significant change from previous NICE recommendations and a significant change in UK practice where only 1.1% of N2 patients currently receive trimodality treatment ( 38 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.